- NOK93.07bn
- NOK136.03bn
- $6.83bn
- 52
- 66
- 52
- 59
2019 December 31st | 2020 December 31st | R2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | NAS | IFRS | IFRS | IFRS | IFRS |
Status: | fx Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 2,855 | 2,894 | 6,071 | 9,816 | 6,834 |
Cost of Revenue | |||||
Gross Profit | 2,017 | 1,837 | 4,929 | 8,673 | 5,697 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 2,094 | 5,147 | 3,012 | 3,448 | 3,318 |
Operating Profit | 762 | -2,253 | 3,059 | 6,369 | 3,517 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 773 | -2,204 | 2,647 | 5,856 | 3,357 |
Provision for Income Taxes | |||||
Net Income After Taxes | 285 | -1,627 | 654 | 936 | 610 |
Net Income Before Extraordinary Items | |||||
Net Income | 285 | -1,627 | 654 | 936 | 610 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 285 | -1,627 | 654 | 936 | 610 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.105 | -0.08 | 0.262 | 0.605 | 0.378 |
Dividends per Share |